SE460096B - Laekemedel foer behandling av diabetes, avsett foer oral administrering - Google Patents

Laekemedel foer behandling av diabetes, avsett foer oral administrering

Info

Publication number
SE460096B
SE460096B SE8201784A SE8201784A SE460096B SE 460096 B SE460096 B SE 460096B SE 8201784 A SE8201784 A SE 8201784A SE 8201784 A SE8201784 A SE 8201784A SE 460096 B SE460096 B SE 460096B
Authority
SE
Sweden
Prior art keywords
insulin
weight
medicament according
minutes
additive
Prior art date
Application number
SE8201784A
Other languages
English (en)
Swedish (sv)
Other versions
SE8201784L (sv
Inventor
A B Davydov
E A Babaian
V I Metelitsa
T P Ostrovskaya
R I Utyamyshev
G L Khromov
E I Chazov
Original Assignee
Vsesojuznyj Kardiologitsches
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vsesojuznyj Kardiologitsches filed Critical Vsesojuznyj Kardiologitsches
Publication of SE8201784L publication Critical patent/SE8201784L/xx
Publication of SE460096B publication Critical patent/SE460096B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8201784A 1981-07-14 1982-03-19 Laekemedel foer behandling av diabetes, avsett foer oral administrering SE460096B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU813303301A SU1011126A1 (ru) 1981-07-14 1981-07-14 Средство дл лечени сахарного диабета

Publications (2)

Publication Number Publication Date
SE8201784L SE8201784L (sv) 1983-01-15
SE460096B true SE460096B (sv) 1989-09-11

Family

ID=20963815

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8201784A SE460096B (sv) 1981-07-14 1982-03-19 Laekemedel foer behandling av diabetes, avsett foer oral administrering

Country Status (10)

Country Link
US (1) US4529589A (ar)
JP (1) JPS5813520A (ar)
CA (1) CA1182046A (ar)
CH (1) CH654211A5 (ar)
DE (2) DE3210194A1 (ar)
FR (1) FR2509613B1 (ar)
GB (1) GB2101482B (ar)
IT (1) IT1189255B (ar)
SE (1) SE460096B (ar)
SU (1) SU1011126A1 (ar)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4842854A (en) * 1979-05-29 1989-06-27 Vsesojuzny Kardiologichesky Nauchny Tsentr Akademii Meditsinskiki Nauk Ssr Antianginal plate for treating ischemic heart disease
US4921695A (en) * 1979-05-29 1990-05-01 Babaian Eduard A Antianginal plate for treating ischemic heart disease
US4713239A (en) * 1979-05-29 1987-12-15 Vsesojuny Kardiologichesky Nauchny Tsentr Adkaemii Meditsinski Nauk Sssr Antianginal film and method of treating ischemic heart disease
SU1011126A1 (ru) * 1981-07-14 1983-04-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Средство дл лечени сахарного диабета
JPS60224638A (ja) * 1984-04-23 1985-11-09 Kao Corp 経皮吸収促進剤およびこれを含有する外用剤
US4863737A (en) * 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
US5855908A (en) * 1984-05-01 1999-01-05 University Of Utah Research Foundation Non-dissolvable drug-containing dosage-forms for use in the transmucosal delivery of a drug to a patient
JPS611621A (ja) * 1984-06-09 1986-01-07 ヘキスト・アクチエンゲゼルシヤフト インシュリン製剤
DE3576120D1 (de) * 1984-06-09 1990-04-05 Hoechst Ag Insulinzubereitungen, verfahren zu deren herstellung und deren verwendung.
DE3443877A1 (de) * 1984-06-09 1985-12-12 Hoechst Ag Insulinzubereitungen, verfahren zu deren herstellung und deren verwendung
US4885173A (en) * 1985-05-01 1989-12-05 University Of Utah Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities
US5132114A (en) * 1985-05-01 1992-07-21 University Of Utah Research Foundation Compositions and methods of manufacture of compressed powder medicaments
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US5122127A (en) * 1985-05-01 1992-06-16 University Of Utah Apparatus and methods for use in administering medicaments by direct medicament contact to mucosal tissues
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
US4849227A (en) * 1986-03-21 1989-07-18 Eurasiam Laboratories, Inc. Pharmaceutical compositions
CA1257199A (en) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation containing bioactive macromolecular substance for multi-months release in vivo
JPH0653634B2 (ja) * 1989-01-13 1994-07-20 三菱マテリアル株式会社 シリコン単結晶引上げ用石英ルツボの再生方法
US5064637A (en) * 1989-05-30 1991-11-12 Board Of Regents, The University Of Texas System Substituted sulfonamide derivatives which inhibit allergic reactions
IL99699A (en) * 1990-10-10 2002-04-21 Autoimmune Inc Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
FR2797767B1 (fr) * 1999-08-27 2002-06-14 Centre Nat Rech Scient Utilisation d'acides amines pour la fabrication de medicaments destines au traitement des insulino-resistances
WO2001091784A1 (en) * 2000-05-26 2001-12-06 C.T.P. Cable Technology Procurement Ag Means for maintenance and/or correction of glucose concentration in blood
ATE460394T1 (de) * 2000-08-29 2010-03-15 Biocon Ltd 5-asa-derivate mit entzündungshemmender und antibiotischer wirkung und verfahren zur behandlung von krankheiten mit diesen derivaten
WO2006095822A1 (ja) * 2005-03-11 2006-09-14 Ono Pharmaceutical Co., Ltd. スルホンアミド化合物およびその医薬

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1547515A (en) * 1923-07-09 1925-07-28 John R Murlin Antidiabetic substance and method of preparing the same
US2474729A (en) * 1945-01-03 1949-06-28 Rhone Poulenc Sa Insulin preparations
DE1017323B (de) * 1952-08-14 1957-10-10 Roskilde Medical Company Ltd Verfahren zur Herstellung von insulinhaltigen Praeparaten mit protrahierter Wirkung
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
US3060093A (en) * 1957-07-18 1962-10-23 Nordisk Insulinlab Slowly acting insulin preparation in crystalline form and method of preparation
GB1060085A (en) * 1963-02-20 1967-02-22 Tintex Corp Method of adhering dentures and compositions therefor
US3312594A (en) * 1963-06-21 1967-04-04 Squibb & Sons Inc Longlasting troche
GB1083896A (en) * 1964-04-30 1967-09-20 Dunster Lab Ltd Vehicles for administering drugs
GB1142325A (en) * 1965-05-14 1969-02-05 Higham Stanley Russell Means for administering drugs
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose
SU504766A1 (ru) * 1970-06-18 1976-02-28 Всесоюзный Научно-Исследовательский Химико-Фармацевтический Институт Имени С.Орджоникидзе Способ получени 5- п-/ -/6метоксипиридазинил-3/ -сульфонамидо/ фенилазо -салициловой кислоты
US3847890A (en) * 1971-11-01 1974-11-12 A Green Acidic monosaccharide-substituted proteins
US3978201A (en) * 1972-11-27 1976-08-31 Gennady Lvovich Khromov Base for ophthalmological medicinal preparation on opthalmological medicinal film
JPS5138412A (en) * 1974-09-24 1976-03-31 Nippon Kayaku Kk Kokoseizai no seiho
DK143689C (da) * 1975-03-20 1982-03-15 J Kreuter Fremgangsmaade til fremstilling af en adsorberet vaccine
US4153689A (en) * 1975-06-13 1979-05-08 Takeda Chemical Industries, Ltd. Stable insulin preparation for nasal administration
GB1563311A (en) * 1975-09-26 1980-03-26 Yamanouchi Pharma Co Ltd Pharmaceutical composition of insulin for rectal use
SU810241A1 (ru) * 1978-03-03 1981-03-07 Всесоюзный Кардиологический Научныйцентр Способ индивидуального дозировани плЕНОчНыХ фОРМ лЕКАРСТВЕННыХСРЕдСТВ
SU806037A1 (ru) * 1978-04-06 1981-02-23 Всесоюзный Кардиологический Научныйцентр Amh Cccp Антиангинальное средство
JPS5562012A (en) * 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
DE3064888D1 (en) * 1979-04-30 1983-10-27 Hoechst Ag Aqueous solutions of proteins stable against denaturization, process for their manufacture, and their utilization
DE2917535C2 (de) * 1979-04-30 1986-10-30 Hoechst Ag, 6230 Frankfurt Gegen Denaturierung beständige Insulinlösungen
JPS55153712A (en) * 1979-05-18 1980-11-29 Kao Corp Insulin pharmaceutical preparation and its production
SU1011126A1 (ru) * 1981-07-14 1983-04-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Средство дл лечени сахарного диабета

Also Published As

Publication number Publication date
IT8248200A0 (it) 1982-04-08
DE3210194A1 (de) 1983-02-03
FR2509613A1 (fr) 1983-01-21
DE3226363A1 (de) 1983-06-01
CA1182046A (en) 1985-02-05
US4529589A (en) 1985-07-16
GB2101482B (en) 1984-08-01
CH654211A5 (de) 1986-02-14
GB2101482A (en) 1983-01-19
IT1189255B (it) 1988-02-04
FR2509613B1 (fr) 1985-11-15
DE3226363C2 (de) 1987-01-08
SE8201784L (sv) 1983-01-15
JPS5813520A (ja) 1983-01-26
SU1011126A1 (ru) 1983-04-15

Similar Documents

Publication Publication Date Title
SE460096B (sv) Laekemedel foer behandling av diabetes, avsett foer oral administrering
WEEKE et al. Inhibition by somatostatin of basal levels of serum thyrotropin (TSH) in normal men
DK1919458T5 (en) Enteric-coated cysteamine, cystamine and derivatives thereof
FR2477843A1 (fr) Produits nutritifs et leur procede d'administration
Muggla-Sullam et al. Postoperative enteral versus parenteral nutritional support in gastrointestinal surgery: A matched prospective study
US6417227B1 (en) Methods of delivery of cetyl myristoleate
Ziv et al. Oral administration of insulin in solid form to nondiabetic and diabetic dogs
Buchanan et al. Effect of pancreozymin on insulin and glucagon levels in blood and bile
EP0649304A1 (en) Composition and methods for decreasing muscle breakdown
EP0351651A2 (en) Insulin preparation
CA2504873C (en) Percutaneous absorption preparation containing 3-methyl-1-phenyl-2-pyrazolin-5-one
Rhode et al. Nitrogen balances of dogs continuously infused with 50 per cent glucose and protein preparations
US6620967B1 (en) Ketosis-treating agent
Maksoud et al. Effect of branched‐chain amino acids and insulin on postinjury protein catabolism in growing animals
US8076368B2 (en) Percutaneous absorption type cerebral protective agent
JP3429327B2 (ja) 癌用アミノ酸輸液剤
Sologub et al. Enteral hyperalimentation of burned patients: the possibility of correcting metabolic disorders by the early administration of prolonged high calorie evenly distributed tube feeds
RU2314824C2 (ru) Препаративная готовая форма для гастроинтестинального введения и ее применение
BE887941A (fr) Produits nutritifs et leur procede d'administration.
Johnston Metabolic foundations of intravenous nutrition
Harano et al. Efficacy of combined insulin and somatostatin infusion for the treatment of experimental diabetic ketoacidosis
US20200170969A1 (en) Reduction of hyperglycemia by administration of dimethylformamide for treating hyperglycemic conditions, including diabetes mellitus
Brandsborg et al. Inhibition of meal-stimulated gastrin secretion after oral glucose
JPH02117620A (ja) 消化管萎縮改善剤
Gupta et al. Total parenteral nutrition

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8201784-9

Effective date: 19911009

Format of ref document f/p: F